A Phase I, Open-Label, Dose-Escalation Study of SEA-CD40 in Adult patients with advanced malignancies

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase I, Open-Label, Dose-Escalation Study of SEA-CD40 in Adult patients with advanced malignancies

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.